Search research articles
Contact Us
Filters
Showing results (251-260 of 267) with videos related to
Page
of 27
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 15, 2005
Cardioprotection mediated by urocortin is dependent on PKCepsilon activation
K M Lawrence, A M N Kabir, M Bellahcene, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics
C O Ogbu, M N Qabar, P D Boatman, et al.
Science (New York, N.Y.)
|
April 12, 2012
Magnetic reconnection in the near Venusian magnetotail
T L Zhang, Q M Lu, W Baumjohann, et al.
ACS Chemical Neuroscience
|
December 15, 2022
Pharmacological Mechanism of the Non-hallucinogenic 5-HT<sub>2A</sub> Agonist Ariadne and Analogs
Michael J Cunningham, Hailey A Bock, Inis C Serrano, et al.
The Review of Scientific Instruments
|
January 3, 2013
New dual gas puff imaging system with up-down symmetry on experimental advanced superconducting tokamak
S C Liu, L M Shao, S J Zweben, et al.
Nature Materials
|
July 26, 2017
A magnetic topological semimetal Sr<sub>1-y</sub>Mn<sub>1-z</sub>Sb<sub>2</sub> (y, z < 0.1)
J Y Liu, J Hu, Q Zhang, et al.
Nature Communications
|
December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Cell Reports
|
March 8, 2023
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M Bonniwell, Janelle K Lanham, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic Potential
Jason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Diabetes Care
|
April 1, 1997
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
X R Pan, G W Li, Y H Hu, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 267) with videos related to
Sort By:
Page
of 27
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 15, 2005
Cardioprotection mediated by urocortin is dependent on PKCepsilon activation
K M Lawrence, A M N Kabir, M Bellahcene, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics
C O Ogbu, M N Qabar, P D Boatman, et al.
Science (New York, N.Y.)
|
April 12, 2012
Magnetic reconnection in the near Venusian magnetotail
T L Zhang, Q M Lu, W Baumjohann, et al.
ACS Chemical Neuroscience
|
December 15, 2022
Pharmacological Mechanism of the Non-hallucinogenic 5-HT<sub>2A</sub> Agonist Ariadne and Analogs
Michael J Cunningham, Hailey A Bock, Inis C Serrano, et al.
The Review of Scientific Instruments
|
January 3, 2013
New dual gas puff imaging system with up-down symmetry on experimental advanced superconducting tokamak
S C Liu, L M Shao, S J Zweben, et al.
Nature Materials
|
July 26, 2017
A magnetic topological semimetal Sr<sub>1-y</sub>Mn<sub>1-z</sub>Sb<sub>2</sub> (y, z < 0.1)
J Y Liu, J Hu, Q Zhang, et al.
Nature Communications
|
December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Cell Reports
|
March 8, 2023
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M Bonniwell, Janelle K Lanham, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic Potential
Jason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Diabetes Care
|
April 1, 1997
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
X R Pan, G W Li, Y H Hu, et al.
Page
of 27